title: LOH analysis should not be used as a tool to assess whether UVs of BRCA1/2 are pathogenic or not.
authors.affiliation: Molecular Genetics Laboratory, Department of Biochemistry, Hospital de Cruces, Pza. de Cruces s/n, 48903, Barakaldo, Bizkaia, Spain. eberistain001@ikasle.ehu.es
authors.forename: E
authors.initials: E
authors.lastname: Beristain
authors.forename: I
authors.initials: I
authors.lastname: Guerra
authors.forename: N
authors.initials: N
authors.lastname: Vidaurrazaga
authors.forename: J
authors.initials: J
authors.lastname: Burgos-Bretones
authors.forename: M I
authors.initials: MI
authors.lastname: Tejada
mesh_terms: D001943:Breast Neoplasms / Q000235:genetics*; D005260:Female; D019398:Genes, BRCA1; D024522:Genes, BRCA2; D020022:Genetic Predisposition to Disease; D006801:Humans; D019656:Loss of Heterozygosity; D010051:Ovarian Neoplasms / Q000235:genetics*